Ifp Advisors, Inc Argenx Se Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Argenx Se stock. As of the latest transaction made, Ifp Advisors, Inc holds 648 shares of ARGX stock, worth $365,621. This represents 0.01% of its overall portfolio holdings.

Number of Shares

648

Previous 614 5.54%

Holding current value

$365,621

Previous $241,000 15.35%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$356.01 - $451.55 $12,104 - $15,352	34 Added 5.54%	648 $278,000
Q1 2024 Jul 30, 2024	SELL	$356.95 - $413.29 $1,784 - $2,066	-5 Reduced 0.81%	614 $241,000
Q4 2023 Jan 09, 2024	SELL	$338.91 - $506.01 $1,016 - $1,518	-3 Reduced 0.48%	619 $235,000
Q3 2023 Oct 12, 2023	SELL	$369.35 - $548.43 $1,108 - $1,645	-3 Reduced 0.48%	622 $305,000
Q2 2023 Aug 04, 2023	SELL	$360.14 - $422.58 $2,881 - $3,380	-8 Reduced 1.26%	625 $243,000
Q1 2023 Apr 18, 2023	SELL	$334.23 - $403.65 $25,735 - $31,081	-77 Reduced 10.85%	633 $235,000
Q4 2022 Feb 07, 2023	BUY	$342.17 - $402.31 $1,368 - $1,609	4 Added 0.57%	710 $90,000
Q3 2022 Nov 08, 2022	BUY	$343.2 - $395.75 $17,160 - $19,787	50 Added 7.62%	706 $90,000
Q2 2022 Sep 06, 2022	BUY	$269.58 - $378.88 $176,844 - $248,545	656 New	656 $69,000
Q2 2022 Aug 12, 2022	SELL	$269.58 - $378.88 $176,844 - $248,545	-656 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$254.45 - $351.06 $65,648 - $90,573	258 Added 64.82%	656 $206,000
Q1 2022 Aug 08, 2022	BUY	$254.45 - $351.06 $1,526 - $2,106	6 Added 1.53%	398 $125,000
Q4 2021 Jan 12, 2022	SELL	$272.01 - $353.03 $544 - $706	-2 Reduced 0.51%	392 $140,000
Q3 2021 Oct 06, 2021	SELL	$295.0 - $350.58 $2,950 - $3,505	-10 Reduced 2.48%	394 $122,000
Q1 2021 Apr 30, 2021	BUY	$268.3 - $380.31 $14,219 - $20,156	53 Added 15.1%	404 $112,000
Q4 2020 Jan 25, 2021	BUY	$248.13 - $308.36 $1,240 - $1,541	5 Added 1.45%	351 $103,000
Q3 2020 Oct 29, 2020	BUY	$215.51 - $272.51 $2,586 - $3,270	12 Added 3.59%	346 $94,000
Q2 2020 Aug 05, 2020	SELL	$127.44 - $232.72 $382 - $698	-3 Reduced 0.89%	334 $73,000
Q1 2020 May 12, 2020	BUY	$108.83 - $165.23 $2,829 - $4,295	26 Added 8.36%	337 $46,000
Q4 2019 Jan 17, 2020	BUY	$106.59 - $164.21 $33,149 - $51,069	311 New	311 $51,000

Others Institutions Holding ARGX

# of Institutions

400

Shares Held

30.9M

Call Options Held

376K

Put Options Held

489K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $31.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account